Skip to content

Drug interactions

Berotralstat + Sitagliptin

Severity: Minor

Berotralstat and Sitagliptin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Berotralstat inhibits P-glycoprotein, and sitagliptin is partly eliminated as an unchanged P-gp substrate. Sitagliptin exposure may therefore rise modestly. Sitagliptin has a wide safety margin, so clinically meaningful toxicity is unlikely.

What this interaction means in plain words

Berotralstat and Sitagliptin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Berotralstat belongs to Miscellaneous; Sitagliptin belongs to Endocrine.

Evidence level: Low

Why it happens

Inhibition of P-glycoprotein efflux by berotralstat, reducing sitagliptin clearance.

What to do

No dose change is usually needed. Monitor glucose and watch for sitagliptin adverse effects such as pancreatitis symptoms or hypoglycemia with co-therapy.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Berotralstat and Sitagliptin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Berotralstat with Sitagliptin?

MediHelp rates the interaction as minor. Berotralstat and Sitagliptin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Berotralstat inhibits P-glycoprotein, and sitagliptin is partly eliminated as an unchanged P-gp substrate. Sitagliptin exposure may therefore rise modestly. Sitagliptin has a wide safety margin, so clinically meaningful toxicity is unlikely.

How serious is the interaction between Berotralstat and Sitagliptin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is usually needed. Monitor glucose and watch for sitagliptin adverse effects such as pancreatitis symptoms or hypoglycemia with co-therapy.

What other medicines interact with Sitagliptin?

MediHelp also lists interactions of Sitagliptin with, for example, Albiglutide, Amlodipine-benazepril, Aripiprazole. The full list is on the Sitagliptin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in